Investor Ideas #Potcasts
596, #Cannabis News and #Stocks on the Move- (NASDAQ: $FLGC), (TSX: $VLNS.TO),
(CSE: $COOL.C), (TSX: $HEXO.TO) (NYSE: $HEXO)
Delta, Kelowna, BC, August 13, 2021 (Investorideas.com Newswire)
www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/081321-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/08131FLGC-VLNS-COOL-HEXO.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
The
Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) today announced the launch of three new
products in partnership with Verse Cannabis ("Verse"), including two
new vape cartridges and the brand's first cannabis-infused beverage. With its
wide range of products under both the Verse Originals and Verse Concentrates
lines, Verse Cannabis now offers products across all categories.
The new products from the Verse
Originals line include:
Rapid
Tropical Rush
The first cannabis-infused beverage
introduced by Verse, Rapid Tropical Rush offers a refreshing twist to classic
water with tangy citrus flavours of lemon and lime and a hint of sweet tropical
ripe mangoes. Each 250ml stubby bottle is infused with 10 mg of THC and 10 mg
of CBD and is equipped with a resealable lid to allow for controlled
consumption. Powered by SōRSE® by Valens technology, this beverage is free of
cannabis taste and smell and offers a quick onset. Rapid Tropical Rush is
currently available in Alberta and British Columbia with Ontario to follow in
the coming weeks, and a variety of additional beverages are expected to launch
from Verse in the coming quarters.
Mango
Nectar Vape Cartridge (1g)
The newest flavour addition to the
top-selling line of vape cartridges from Verse, this high-potency vape
cartridge offers a unique terpene-rich blend of fruity and distinctively sweet
mango flavours inspired by the popular Mango Haze strain. Formulated using
Valens' proprietary, ultra-refined extraction processes, the Mango Nectar vape
cartridge is comprised of ultra-pure distillate. The cartridge also comes in
several other flavours, including Tropic Lemon, Sunset Peach, Mandarin Mint,
and Summer Berry, all available in participating Canadian markets, with Mango Nectar
currently available in Alberta and arriving in Ontario in the coming weeks.
Verse has also launched a new
addition to the Live Terp series under the Verse Concentrates line, the Live Terp Guava x BC Blueberry 510 Vape
Cartridge (1g), now available in Alberta and soon to be available in
British Columbia and Ontario. This
Indica dominant cartridge packs in strong punches of citrus and sour blueberry
that develops into a gassy pine finish. Using CO2 extraction, the complete
terpene-rich profile of fresh-frozen whole flower is removed, and extracted
live terpenes are then added to a highly refined distillate for a smooth, rich
pull. The Live Terp Guava x BC Blueberry Vape Cartridge follows the
introduction of the Killer Kush Live Terp Vape Cartridge released earlier this
summer, available in participating Canadian markets.
Core
One Labs Inc. (CSE: COOL), (OTC: CLABD), a research and technology company
focused in life sciences and on bringing psychedelic medicines to market
through novel delivery systems and psychedelic assisted psychotherapy, announced that its wholly owned subsidiaries,
Rejuva Mental Health Clinic and Bluejay Mental Health Group Inc., have partnered
to assist their patient with completing an application for exemption under
section 56(1) of the Controlled Drugs and
Substances Act of Canada for the purpose of legally accessing psilocybin
for psychedelic-assisted therapy.
In Canada, psychedelics are
classified as controlled substances under the CDSA, and are prohibited for all
use, unless a successful application for exemption under section 56 of the Act
is made to the Federal Minister of Health. Section 56 allows the Federal
Minister of Health to exempt persons or controlled substances if “the exemption
is necessary for a medical or scientific purpose or is otherwise in the public
interest” (Health Canada).
In recent years Health Canada has
endeavored to increase access to psychedelic medicine for patients facing
mental health challenges, including providing select approvals for exemption
under Section 56 of the CDSA. On August 4, 2020, Patty Hadju, Canada’s Federal
Minister of Health granted the first legal exemptions from the CDSA under
section 56(1), on compassionate grounds, to four Canadians with incurable
cancer to receive psilocybin therapy to treat their anxiety.
Bluejay’s wholly owned subsidiary,
GreenLeaf Medical Clinic (EST 2011), was one of the first specialized medical
cannabis clinics in Canada and continues to assess patients for the
appropriateness of medical cannabis into Health Canada’s Access to Cannabis for
Medical Purposes Regulations (ACMPR). The management team has worked closely
with Health Canada, developing a strong understanding for compliance. They have
also led educators in cannabinoid therapy and have worked with thousands of
patients, doctors and cultivators. Bluejay intends to be one of the first
clinics to have its patients granted the section 56(1) exemption as it has been
at the forefront of the progressive health movement for years.
Core One is focused on advancing the
use of psychedelics as alternative modalities to treating mental health
afflictions, and part of this advancement is supporting and assisting patients
in gaining access to such alternatives through the Company’s various
Canadian-based medical and research clinics.
“With a growing roster of clinics
under our umbrella, Core One continues to execute on its long-term goal of
developing an internal patient base for its biosythensized psilocybin and
psychedelic treatments. Submitting the application for a section 56(1)
exemption is the next step in allowing our patients access to these varieties
of treatments, and as one of the first companies to do so, we will be
positioned as a leader in the adoption of exemptions for patients. This
scalable business model has untapped potential as patients begin to receive
exemptions for mental health issues ranging from depression to addiction,”
stated Joel Shacker CEO of the Company.
HEXO
Corp
(TSX: HEXO) (NYSE: HEXO) announced today it has applied to transfer its
U.S. stock exchange listing from the New York Stock Exchange to the Nasdaq.
While this transfer remains subject to the approval of the Nasdaq, the Company
expects the transfer to occur effective August 23, 2021 after market close.
Common shares of HEXO are expected to begin trading as a Nasdaq-listed security
on August 24, 2021, with the shares continuing to trade under the symbol
“HEXO”.
“Transferring our U.S. listing to
Nasdaq allows us to generate shareholder value through greater cost savings on
our path towards profitability, while joining our peers on a leading global
exchange,” said HEXO CEO and co-founder Sebastien St-Louis. “We are grateful
for the partnership and support that the New York Stock Exchange has provided
to us, allowing us to be one of the first publicly traded cannabis companies in
the US.”
Current retail and institutional
investor shares will automatically be transferred over to Nasdaq and current
shareholders are not required to take any action. The last day of trading of
the Company’s common stock on NYSE is expected to be August 23, 2021.
Flora
Growth Corp. (NASDAQ: FLGC) announced the availability of a broadcast
titled, “Colombia Challenges Canadian Cannabis Dominance.”
To hear the AudioPressRelease,
please visit: The NetworkNewsAudio News Podcast
To view the full editorial, please
visit: https://nnw.fm/p1UWI
Near-perfect growing conditions,
skilled labor and friendly regulations have underscored Colombia’s emergence in
the legal cannabis space since the country first allowed the production of
medical cannabis just over five years ago. However, until now, dried cannabis
flower, or buds, could only be processed for export as a medicinal oil or
extract for fear that flowers would find their way to the black market. The new
law puts Colombia “at the forefront in terms of regulatory competitiveness,”
according to President Duque, adding that his country will now participate in
new markets, including food, beverages, cosmetics, and textiles, in addition to
pharmaceuticals. . .
These circumstances may play right
into the hands of Flora Growth Corp., as well as other Colombian licensed
producers which have focused on cannabis cultivation and processing operations
in Colombia to supply international markets. The new decree could prove to be a
bonanza for established licensed producers, especially when considering the
extremely low production costs and that dried cannabis flower represents the
majority of sales in countries with mature markets, such as the United States,
Germany, United Kingdom, and Australia.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com
podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts is now
a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com -
News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for
iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment